SEC Form 4 · accession 0001185185-15-001013
Entia Biosciences, Inc. · ERGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marvin S Hausman M.D.
Officer — CEO, President, Acting CFO · Director · 10% Owner
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 11:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001408299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 24, 2015 | A | 600,000 | $0.20 | A | 4,757,200 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The shares of common stock were issued to Dr. Hausman in payment of annual bonus.